These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 3495674)

  • 1. Cholesterol reduction in coronary artery bypass patients.
    Passamani ER
    JAMA; 1987 Jun; 257(23):3271-2. PubMed ID: 3495674
    [No Abstract]   [Full Text] [Related]  

  • 2. Platelets and thrombosis in vein graft occlusion: role and prevention.
    Lam JY; Solymoss BC; Campeau L
    Cardiovasc Clin; 1991; 21(2):67-81. PubMed ID: 2044097
    [No Abstract]   [Full Text] [Related]  

  • 3. Haemostatic factors and inhibitors and coronary artery bypass grafting: preoperative alterations and relations to graft occlusion.
    Moor E; Hamsten A; Blombäck M; Herzfeld I; Wiman B; Rydén L
    Thromb Haemost; 1994 Sep; 72(3):335-42. PubMed ID: 7531874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts.
    Mukamal KJ; Girotra S; Mittleman MA
    Am Heart J; 2006 Feb; 151(2):368-72. PubMed ID: 16442902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between saphenous coronary bypass graft occlusion and serum gamma-glutamyltransferase activity.
    Demirkan B; Güray Y; Güray Ü; Turak O; Hajro E; Korkmaz S
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):321-6. PubMed ID: 21200101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Stein PD; Schünemann HJ; Dalen JE; Gutterman D
    Chest; 2004 Sep; 126(3 Suppl):600S-608S. PubMed ID: 15383486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late thrombolysis with intracoronary streptokinase after myocardial infarction.
    Schechter E; Prabhu S
    Cathet Cardiovasc Diagn; 1986; 12(3):172-5. PubMed ID: 3488129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of nitroglycerin and isosorbiddinitrate on myocardial perfusion and hemodynamics in patients with and without coronary disease.
    Simon R; Amende I; Engel HJ; Lichtlen PR
    Scand J Clin Lab Invest Suppl; 1984; 173():47-58. PubMed ID: 6442002
    [No Abstract]   [Full Text] [Related]  

  • 9. Higher platelet activity is present in patients with restenosis after percutaneous coronary intervention compared with patients with an occlusion of coronary artery bypass graft.
    Osmancik PP; Bednar F; Pavkova L; Tousek P; Stros P; Jirasek K
    Blood Coagul Fibrinolysis; 2008 Dec; 19(8):807-12. PubMed ID: 19002048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of early graft occlusion after coronary bypass grafting by post-operative reduction of plasma fibrinogen by H.E.L.P. apheresis. First evaluation of 12 patients treated during our study (44 bypasses)].
    Blessing F; Jaeger BR; Oberhoffer M; Reichart B; Seidel D
    Z Kardiol; 2003; 92(Suppl 3):III42-7. PubMed ID: 14663601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin-antithrombin complexes and prothrombin fragment 1+2 in aorto-coronary bypass surgery: relation to graft occlusion.
    Rifón J; Páramo JA; Prósper F; Collados MT; Sarrá J; Rocha E
    Hematol Pathol; 1994; 8(1-2):35-42. PubMed ID: 8034556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of arrhythmias in the postbypass patient.
    Talajic M; Lemery R; Roy D; Pelletier LC
    Cardiovasc Clin; 1991; 21(2):211-26. PubMed ID: 2044089
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlates of saphenous vein graft hyperplasia and occlusion 1 year after coronary artery bypass grafting: analysis from the CASCADE randomized trial.
    Une D; Kulik A; Voisine P; Le May M; Ruel M
    Circulation; 2013 Sep; 128(11 Suppl 1):S213-8. PubMed ID: 24030409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of lipid-lowering medications and low-density lipoprotein levels on 1-year clinical outcomes after coronary artery bypass grafting.
    Quin JA; Hattler B; Bishawi M; Baltz J; Gupta S; Collins JF; Grover FL; McDonald G; Shroyer AL
    J Am Coll Surg; 2013 Sep; 217(3):452-60. PubMed ID: 23891072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation factors as predictors of transplant-associated coronary artery disease.
    Labarrere CA
    J Heart Lung Transplant; 2000 Jul; 19(7):623-33. PubMed ID: 10930810
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effects of cholesterol-lowering therapy on the results of coronary arterial stenting in patients with chronic forms of coronary heart disease].
    Arablinskiĭ AV; Zakharova OV; Ioseliani DG
    Klin Med (Mosk); 2006; 84(7):13-6. PubMed ID: 16924793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors influencing aorto-coronary vein graft deterioration: influence of the plasma lipids.
    Lawrie M
    Beitr Infusionsther; 1988; 23():97-102. PubMed ID: 2484788
    [No Abstract]   [Full Text] [Related]  

  • 18. [Elevated levels of plasma homocysteine related to saphenous vein graft disease after coronary artery bypass graft surgery].
    Iwama Y; Mokuno H; Yokoi H; Daida H; Yamaguchi H; Hosoda Y
    J Cardiol; 1998 Dec; 32(6):357-62. PubMed ID: 9914952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombocytes, blood coagulation factors and fibrinolysis following aortocoronary venous bypass operation].
    Zöller H; Süss W; Gross W
    Vasa Suppl; 1991; 32():305-8. PubMed ID: 1771520
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum matrix metalloproteinase-9 and venous bypass graft occlusion.
    Kalela A; Limnell V; Aittoniemi J; Virtanen V; Jaakkola O; Lehtimäki T; Nikkari ST
    Scand J Clin Lab Invest; 2006; 66(1):7-14. PubMed ID: 16464782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.